Aimmune Prepares For IPO By Setting Expected Price Range
ThinkstockAimmune Therapeutics, Inc. filed an S-1 form with the Securities and Exchange Commission (SEC) for its initial public offering. The expected price range was set as $14 to $16 for 8.33 million shares with…